High and Low Intensity Speech Intervention in Children with a Cleft Palate: Perceptions of Children, Their Caregivers and Speech-language Pathologists
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Tara Mouton
- Phone Number: +32 496 44 63 08
- Email: tara.mouton@ugent.be
Study Locations
-
-
-
Ghent, Belgium, 9000
- Recruiting
- Ghent University Hospital
-
Contact:
- Kristiane Van Lierde
- Phone Number: +32 9 332 01 43
- Email: kristiane.vanlierde@uzgent.be
-
Contact:
- Tara Mouton
- Phone Number: +32 9 332 01 43
- Email: tara.mouton@ugent.be
-
Contact:
- Kristiane Van Lierde, Professor
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Belgian Dutch-speaking children with a cleft palate with or without a cleft lip
- Aged between 4 and 12 years,
- Presence of at least one compensatory speech error in their speech based on the perceptual assessment of one experienced speech-language pathologist
Exclusion Criteria:
- Children with syndromic clefts
- Oronasal fistula
- Velopharyngeal insufficiency
- Hearing disabilities based on pure tone audiometry (>25 dB HL)
- Cognitive and/or related learning disabilities or neuromuscular disorders
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perceptions and acceptability of low/high intensive speech intervention
Time Frame: 20 weeks
|
Participants will be interviewed and can talk about their experiences and perceptions regarding the speech intervention intensity.
The acceptability of both high and low intensive therapy will be examined
|
20 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Neurologic Manifestations
- Musculoskeletal Diseases
- Mouth Diseases
- Stomatognathic Diseases
- Nervous System Diseases
- Jaw Diseases
- Neurobehavioral Manifestations
- Jaw Abnormalities
- Maxillofacial Abnormalities
- Craniofacial Abnormalities
- Musculoskeletal Abnormalities
- Stomatognathic System Abnormalities
- Congenital Abnormalities
- Lip Diseases
- Communication Disorders
- Language Disorders
- Mouth Abnormalities
- Speech Disorders
- Cleft Lip
- Cleft Palate
Other Study ID Numbers
Other Study ID Numbers
- ONZ-2024-0191
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.